X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (352) 352
Patent (30) 30
Trade Publication Article (7) 7
Newspaper Article (4) 4
Conference Proceeding (3) 3
Book Chapter (2) 2
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (114) 114
female (78) 78
male (78) 78
hematology (74) 74
aged (69) 69
middle aged (65) 65
adult (52) 52
oncology (41) 41
aged, 80 and over (39) 39
treatment outcome (39) 39
leukemia, lymphocytic, chronic, b-cell - drug therapy (35) 35
leukemia (31) 31
abridged index medicus (30) 30
human necessities (30) 30
hygiene (30) 30
medical or veterinary science (30) 30
preparations for medical, dental, or toilet purposes (30) 30
antineoplastic agents - therapeutic use (28) 28
therapy (28) 28
rituximab (27) 27
pyrimidines - therapeutic use (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
survival (24) 24
disease-free survival (23) 23
cll (22) 22
fludarabine (21) 21
pyrimidines - adverse effects (21) 21
clinical trials and observations (20) 20
hematology, oncology and palliative medicine (20) 20
recurrence (20) 20
follow-up studies (19) 19
remission induction (19) 19
chemotherapy (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (18) 18
leukemia, lymphocytic, chronic, b-cell - mortality (17) 17
prognosis (17) 17
pyrazoles - adverse effects (17) 17
adolescent (16) 16
antineoplastic agents - adverse effects (16) 16
chronic lymphatic leukemia (16) 16
cancer (15) 15
lymphoma (15) 15
open-label (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
inhibitor (14) 14
patients (14) 14
pyrazoles - therapeutic use (14) 14
young adult (14) 14
drug therapy (13) 13
imatinib mesylate (13) 13
medicine, general & internal (13) 13
benzamides (12) 12
care and treatment (12) 12
cyclophosphamide (12) 12
survival analysis (12) 12
time factors (12) 12
chronic lymphocytic-leukemia (11) 11
clinical trials (11) 11
hemic and lymphatic diseases (11) 11
kaplan-meier estimate (11) 11
lymphatic leukemia (11) 11
mutation (11) 11
piperazines - therapeutic use (11) 11
protein kinase inhibitors - therapeutic use (11) 11
risk factors (11) 11
chronic myeloid-leukemia (10) 10
initial therapy (10) 10
multicenter (10) 10
protein-tyrosine kinases - antagonists & inhibitors (10) 10
purines - adverse effects (10) 10
pyrimidines - administration & dosage (10) 10
quinazolinones - adverse effects (10) 10
survival rate (10) 10
trans-retinoic acid (10) 10
animals (9) 9
chlorambucil (9) 9
chronic lymphocytic leukemia (9) 9
ibrutinib (9) 9
leukemia, lymphocytic, chronic, b-cell - pathology (9) 9
salvage therapy (9) 9
analysis (8) 8
antibodies, monoclonal - therapeutic use (8) 8
chronic myelogenous leukemia (8) 8
dose-response relationship, drug (8) 8
immunotherapy (8) 8
kinases (8) 8
leukemia, promyelocytic, acute - drug therapy (8) 8
lymphomas (8) 8
minimal residual disease (8) 8
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8) 8
protein kinase inhibitors - adverse effects (8) 8
purines - therapeutic use (8) 8
pyrazoles - administration & dosage (8) 8
risk (8) 8
tyrosine (8) 8
alemtuzumab (7) 7
chromosome deletion (7) 7
clinical trials as topic (7) 7
diagnosis (7) 7
diarrhea (7) 7
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (394) 394
French (7) 7
Chinese (4) 4
German (4) 4
Portuguese (3) 3
Spanish (2) 2
Danish (1) 1
Greek (1) 1
Polish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 768 - 778
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 6, pp. 676 - 683
Journal Article
Journal Article
Journal Article
British journal of haematology, ISSN 1365-2141, 2018, Volume 184, Issue 4, pp. 558 - 569
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 11, pp. 997 - 1007
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 25, pp. 2425 - 2437
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 1, pp. 32 - 42
Ibrutinib inhibits Bruton's tyrosine kinase, a component of normal B-cell activation pathways. Ibrutinib produced responses in 71% of patients with refractory... 
MEDICINE, GENERAL & INTERNAL | BRUTONS TYROSINE KINASE | ACTIVATION | RITUXIMAB | B-CELL MALIGNANCIES | PCI-32765 | SURVIVAL SIGNALS | KAPPA-B | INHIBITOR | ANTIGEN RECEPTOR | FLUDARABINE | Recurrence | Pyrazoles - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Pyrazoles - pharmacokinetics | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Treatment Outcome | Pyrimidines - pharmacology | Remission Induction | Disease-Free Survival | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Chronic lymphocytic leukemia | Care and treatment | Product development | Antineoplastic agents | Tyrosine | Cell proliferation | Pharmacodynamics | Chronic lymphatic leukemia | Cell survival | Leukemia | Diarrhea | Fatigue | Lymphatic leukemia | Kinases | Lymphoma | Bruton's tyrosine kinase | Patients | Risk factors | Cell adhesion & migration | Clonal deletion | Lymphocytes B | Respiratory tract diseases | Lymphomas | Pharmacokinetics | Lymphocytosis | Protein-tyrosine kinase | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 3, pp. 213 - 223
Journal Article